Clearpoint Neuro Inc
NASDAQ:CLPT

Watchlist Manager
Clearpoint Neuro Inc Logo
Clearpoint Neuro Inc
NASDAQ:CLPT
Watchlist
Price: 11.9 USD -0.5%
Market Cap: 328.2m USD
Have any thoughts about
Clearpoint Neuro Inc?
Write Note

Clearpoint Neuro Inc
Depreciation & Amortization

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Clearpoint Neuro Inc
Depreciation & Amortization Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Depreciation & Amortization CAGR 3Y CAGR 5Y CAGR 10Y
Clearpoint Neuro Inc
NASDAQ:CLPT
Depreciation & Amortization
$926k
CAGR 3-Years
51%
CAGR 5-Years
46%
CAGR 10-Years
10%
Becton Dickinson and Co
NYSE:BDX
Depreciation & Amortization
$2.3B
CAGR 3-Years
1%
CAGR 5-Years
0%
CAGR 10-Years
15%
Boston Scientific Corp
NYSE:BSX
Depreciation & Amortization
$1.2B
CAGR 3-Years
15%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Stryker Corp
NYSE:SYK
Depreciation & Amortization
$1B
CAGR 3-Years
2%
CAGR 5-Years
6%
CAGR 10-Years
11%
Abbott Laboratories
NYSE:ABT
Depreciation & Amortization
$3.2B
CAGR 3-Years
-3%
CAGR 5-Years
1%
CAGR 10-Years
7%
Intuitive Surgical Inc
NASDAQ:ISRG
Depreciation & Amortization
$497.9m
CAGR 3-Years
15%
CAGR 5-Years
22%
CAGR 10-Years
21%
No Stocks Found

Clearpoint Neuro Inc
Glance View

Market Cap
328.3m USD
Industry
Health Care

Clearpoint Neuro, Inc. engages in the development and commercialization of platforms for performing minimally invasive surgical procedures in the brain and heart. The company is headquartered in Solana Beach, California and currently employs 80 full-time employees. The company went IPO on 2019-07-03. The Company’s product platforms include SmartFlow Cannula and ClearPoint Navigation System Software. The SmartFlow Cannula is being utilized in approved combination product clinical and preclinical studies by pharmaceutical companies and academic research customers for various research and clinical trials in connection with delivery of therapeutic agents. The ClearPoint Navigation System Software is a software for surgical planning, navigation to target, and device delivery. The Company’s software and MRI-compatible workstation coordinate with the scanner to effectively utilize intraprocedural MR images. This provides real-time navigational instruction for the neurosurgeon to reach the desired anatomical target with a high degree of precision.

CLPT Intrinsic Value
6.91 USD
Overvaluation 42%
Intrinsic Value
Price

See Also

What is Clearpoint Neuro Inc's Depreciation & Amortization?
Depreciation & Amortization
926k USD

Based on the financial report for Sep 30, 2024, Clearpoint Neuro Inc's Depreciation & Amortization amounts to 926k USD.

What is Clearpoint Neuro Inc's Depreciation & Amortization growth rate?
Depreciation & Amortization CAGR 10Y
10%

Over the last year, the Depreciation & Amortization growth was 101%. The average annual Depreciation & Amortization growth rates for Clearpoint Neuro Inc have been 51% over the past three years , 46% over the past five years , and 10% over the past ten years .

Back to Top